Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi-Reference-Cited by-同舟云学术

Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

Published:2023-12 Issue: Volume:34 Page:102066
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Cavazza Alessia,Hendel Ayal,Bak Rasmus O.,Rio Paula,Güell Marc,Lainšček Duško,Arechavala-Gomeza Virginia,Peng Ling,Hapil Fatma Zehra,Harvey Joshua,Ortega Francisco G.,Gonzalez-Martinez Coral,Lederer Carsten W.,Mikkelsen Kasper,Gasiunas Giedrius,Kalter Nechama,Gonçalves Manuel A.F.V.,Petersen Julie,Garanto Alejandro,Montoliu Lluis,Maresca Marcello,Seemann Stefan E.,Gorodkin Jan,Mazini Loubna,Sanchez Rosario,Rodriguez-Madoz Juan R.,Maldonado-Pérez Noelia,Laura Torella,Schmueck-Henneresse Michael,Maccalli Cristina,Grünewald Julian,Carmona Gloria,Kachamakova-Trojanowska Neli,Miccio Annarita,Martin Francisco,Turchiano Giandomenico,Cathomen Toni,Luo Yonglun,Tsai Shengdar Q.,Benabdellah Karim

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference72 articles.

1. A truncated reverse transcriptase enhances prime editing by split AAV vectors;Gao;Mol. Ther.,2022

2. Multiplex base- and prime-editing with drive-and-process CRISPR arrays;Yuan;Nat. Commun.,2022

3. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi;Jensen;Genome Res.,2021

4. A catalogue of biochemically diverse CRISPR-Cas9 orthologs;Gasiunas;Nat. Commun.,2020

5. A new family of CRISPR-type V nucleases with C-rich PAM recognition;Urbaitis;EMBO Rep.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug outcomes research and policies – trends and challenges;Frontiers in Pharmacology;2024-08-26

2. Genome-wide pan-GPCR cell libraries accelerate drug discovery;Acta Pharmaceutica Sinica B;2024-06